This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its unique trifluoromethyl group enhances the metabolic stability and binding affinity of the resulting compounds, making it valuable in drug discovery. It is particularly relevant in the development of central nervous system (CNS) drugs, where it contributes to the creation of potential therapeutic agents targeting neurological disorders. Additionally, its structural features are explored in the design of enzyme inhibitors and receptor modulators, aiding in the study of complex biochemical pathways.